Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
In Vitro Fertilization01:24

In Vitro Fertilization

In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ophthalmic artery Doppler: reference values in low-risk pregnant women.

Archives of gynecology and obstetrics·2026
Same author

The EXTra-uterine Environment for Neonatal Development (EXTEND) - future treatment for prematurity and potentially other congenital disease.

Seminars in pediatric surgery·2026
Same author

Delivery room resuscitation of conjoined twins.

Journal of perinatology : official journal of the California Perinatal Association·2026
Same author

Ventricle Width and Cerebrospinal Fluid Diversion Rate after Open Fetal Spina Bifida Repair: A 4-Year Follow-Up.

Fetal diagnosis and therapy·2026
Same author

Extracorporeal Circuit for Evaluating Pharmacological Interventions in Umbilical Venous Spasm Using Porcine Umbilical Cords.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Maternal Subcutaneous Seroma following Open Maternal Fetal Surgery for Closure of Fetal Open Neural Tube Defects.

Fetal diagnosis and therapy·2026

Related Experiment Video

Updated: Jun 13, 2026

Ex Utero Culture of Mouse Embryos from Pregastrulation to Advanced Organogenesis
07:14

Ex Utero Culture of Mouse Embryos from Pregastrulation to Advanced Organogenesis

Published on: October 19, 2021

Ex Utero Artificial Womb Support: Promising Future for Extremely Preterm Infants.

Julia Wawrla-Zepf1, Alan W Flake2

  • 1Center for Fetal Research, Children's Hospital of Philadelphia, 3615 Civic Center Boulevard, Philadelphia, PA 19104, USA.

Clinics in Perinatology
|June 11, 2026
PubMed
Summary

Extremely preterm infants face severe health risks. Artificial womb and artificial placenta technologies aim to improve survival and reduce complications by treating these infants as fetuses, moving closer to clinical application.

Keywords:
Artificial placentaArtificial womb technologyExtreme prematurity

Related Experiment Videos

Last Updated: Jun 13, 2026

Ex Utero Culture of Mouse Embryos from Pregastrulation to Advanced Organogenesis
07:14

Ex Utero Culture of Mouse Embryos from Pregastrulation to Advanced Organogenesis

Published on: October 19, 2021

Area of Science:

  • Neonatal medicine
  • Biomedical engineering
  • Developmental biology

Background:

  • Extremely preterm infants (born before 28 weeks' gestation) have high risks of chronic lung disease and neurodevelopmental impairment.
  • Organ immaturity and iatrogenic injury contribute to poor outcomes in extremely preterm infants.
  • Current neonatal care practices may not adequately address the unique vulnerabilities of extremely preterm infants.

Purpose of the Study:

  • To outline the rationale for developing artificial womb (AW) and artificial placenta (AP) technologies.
  • To differentiate between AW and AP technologies and describe their characteristics.
  • To review experimental progress and identify challenges for the clinical translation of AW and AP.

Main Methods:

  • Review of existing literature on artificial womb and artificial placenta technologies.
  • Analysis of experimental data and technological advancements.
  • Identification of key challenges in transitioning these technologies to clinical practice.

Main Results:

  • Artificial womb and artificial placenta technologies have been investigated for over 60 years.
  • Recent advancements suggest these technologies are nearing human application.
  • Significant experimental progress has been made, but challenges remain for clinical translation.

Conclusions:

  • Artificial womb and artificial placenta technologies offer a promising approach to improve outcomes for extremely preterm infants.
  • Treating extremely preterm infants as fetuses using these technologies could mitigate risks associated with organ immaturity and iatrogenic injury.
  • Further research and development are crucial to overcome remaining challenges and enable clinical implementation.